Anti‐TIF1‐γ‐associated dermatomyositis associated with recurrent metastatic triple‐negative breast cancer: Dramatic clinical response to sacituzumab govitecan

Saved in:

Bibliographic Details
Published in	Journal der Deutschen Dermatologischen Gesellschaft Vol. 22; no. 7; pp. 1008 - 1011
Main Authors	Wang, Wei‐Yao, Lee, Chin‐Yu, Hu, Stephen Chu‐Sung
Format	Journal Article
Language	English
Published	Germany Wiley Subscription Services, Inc 01.07.2024
Subjects	Antibodies, Monoclonal, Humanized - therapeutic use Anti‐transcriptional intermediary factor 1 gamma antibody Autoimmune diseases Breast cancer Camptothecin - analogs & derivatives Camptothecin - therapeutic use Dermatomyositis Dermatomyositis - drug therapy Dermatomyositis - pathology Female Humans Immunoconjugates Metastases Middle Aged Monoclonal antibodies Neoplasm Recurrence, Local - drug therapy paraneoplastic syndrome sacituzumab govitecan Targeted cancer therapy Transcription Factors Treatment Outcome Triple Negative Breast Neoplasms - drug therapy Triple Negative Breast Neoplasms - pathology Tumors breast cancer sacituzumab govitecan dermatomyositis Anti‐transcriptional intermediary factor 1 gamma antibody paraneoplastic syndrome
Online Access	Get full text
ISSN	1610-0379 1610-0387 1610-0387
DOI	10.1111/ddg.15399

More Information
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Case Study-3 ObjectType-Correspondence-1 content type line 23 ObjectType-Report-2
ISSN:	1610-0379 1610-0387 1610-0387
DOI:	10.1111/ddg.15399